Biosimilar Analytical Strategies

Effective management of a current good manufacturing practice (GMP) facility requires a strict eye on all those factors. This also includes Bioanalytical methods, Formulation, Bioassay for comparability and potency testing, GMP protein analysis, LC/MS analysis for discovery, preclinical, and clinical programs.Analysis of Biosimilars and biologics forms to be one of the most important aspect towards the biologics and biosimilar development process.

On average, facilities outsource 32% of their analytical testing/bioassays (up from 28%) meaning that close to one-third of analytical testing is estimated to be outsourced by the industry.

Analysis of Biosimilars and biologics forms to be one of the most important aspect towards the biologics and biosimilar development process.Effective management of a current good manufacturing practice (GMP) facility requires a strict eye on all those factors. This also includes Bioanalytical methods, Formulation, Bioassay for comparability and potency testing, GMP protein analysis, LC/MS analysis for discovery, preclinical, and clinical programs.

On average, facilities outsource 32% of their analytical testing/bioassays (up from 28%) meaning that close to one-third of analytical testing is estimated to be outsourced by the industry.

  • Biosimilar bioanalytical methods
  • Biosimilar formulation
  • Bioassay for comparability and potency testing
  • Biosimilar GMP protein analysis
  • Biosimilar LC/MS analysis for discovery, preclinical, and clinical programs
  • Biosimilar electrophoresis
  • Biosimilar multimodal techniques

Related Conference of Biosimilar Analytical Strategies

Biosimilar Analytical Strategies Conference Speakers